Altamira Therapeutics Ltd (CYTO)’s stock is trading at $2.58 at the moment marking a rise of 48.84% from the last session close. As of this writing, shares are priced at -95.05% less than their 52-week high of $52.00, and 59.94% over their 52-week low of $1.61. Based on the past 30-day period, the stock price is -24.53% below the high and +62.59% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CYTO’s SMA-200 is $5.4030.
How does Altamira Therapeutics Ltd (CYTO) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Altamira Therapeutics Ltd (NASDAQ: CYTO) Ownership Details
I will give a breakdown of the key shareholders in Altamira Therapeutics Ltd (CYTO). Recent figures show that the company’s insiders hold 1.27% of shares. A total of 5 institutional investors hold shares in the company, making 0.49% of its stock and 0.49% of its float.
Dec 30, 2023, it was reported that the Company’s largest institutional holder is UBS Group AG holding total of 6814.0 shares that make 0.48% of the company’s total number of shares and are currently priced at 17443.0.
The securities firm Tower Research Capital LLC (TRC) holds 851.0 shares of CYTO, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.06%, and the holding percentage of shares is valued at 2178.0.
An overview of Altamira Therapeutics Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Altamira Therapeutics Ltd (CYTO) traded 2,579,461 shares per day, with a moving average of $1.9032 and price change of +0.7940. With the moving average of $1.9630 and a price change of -0.1060, about 1,131,627 shares changed hands on average over the past 50 days. Finally, CYTO’s 100-day average volume is 1,126,357 shares, alongside a moving average of $3.1419 and a price change of -0.4240.
